Chemical Identity and Structure

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid is an aromatic boronic ester in which a pinacol boronate group is installed at the 5-position of a 2-methylbenzoic acid scaffold. The pinacol (4,4,5,5-tetramethyl-1,3,2-dioxaborolane) protecting group confers improved bench stability and lipophilicity compared with the parent boronic acid, while remaining readily hydrolyzable or directly reactive under standard palladium-catalyzed coupling conditions.

The molecule therefore carries two orthogonally reactive handles: the boronate ester, which participates in Suzuki–Miyaura and related cross-couplings, and the free carboxylic acid, which is available for amide-bond formation, esterification, or coordination chemistry. The 2-methyl substituent introduces steric bias that can influence regioselectivity and conformational preference in downstream targets.

Synthetic Applications in Cross-Coupling Chemistry

The principal application of this compound is as an aryl boronate component in palladium-catalyzed Suzuki–Miyaura cross-coupling reactions. In this widely used methodology, the aryl–boron bond is activated by base to generate a nucleophilic boronate anion that undergoes transmetalation with a palladium(II) intermediate, followed by reductive elimination to form a new C–C bond. Common coupling partners include aryl and heteroaryl halides or triflates.

The retention of the free carboxylic acid distinguishes this reagent from simpler arylboronates: after coupling, the acid functionality can be elaborated to amides, esters, or heterocycles, enabling rapid access to structurally diverse libraries. This makes M693000 particularly attractive in medicinal chemistry fragment-based drug discovery workflows and in the preparation of functionalized biaryl or terphenyl scaffolds used in liquid-crystal and OLED materials research.

The pinacol boronate may also be deprotected to the free boronic acid under mild aqueous acidic conditions when required for applications such as boron neutron capture therapy (BNCT) research or covalent lectin-binding studies.

Handling, Storage, and Safety Considerations

As with most arylboronic ester derivatives, 2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid should be stored in a cool, dry, well-ventilated area, away from moisture and strong oxidizing agents. Pinacol boronates are generally more stable to hydrolysis than free boronic acids, but prolonged exposure to humid air may lead to partial conversion to the boronic acid or boroxine oligomers, which can reduce purity. Storage under inert gas (nitrogen or argon) at 2–8 °C or at room temperature in a desiccated environment is recommended to maintain long-term integrity.

Standard laboratory personal protective equipment (PPE) — including nitrile gloves, safety goggles, and a lab coat — should be worn during handling. The compound should be treated as a potential irritant; inhalation of dust should be avoided. Users should consult the Safety Data Sheet (SDS) provided by Aladdin Scientific for complete hazard information before use.

For weighing operations, use a closed-container technique or work in a fume hood to minimize dust generation. Solutions in common organic solvents (THF, DMF, dioxane, ethyl acetate, or dichloromethane) are typically prepared at the point of use to avoid prolonged solution-phase degradation.

Role in Medicinal Chemistry and Drug Discovery

Bifunctional arylboronate building blocks are highly sought-after in medicinal chemistry because they allow sequential elaboration of a molecular scaffold in two orthogonal directions. For M693000, the carboxylic acid moiety enables direct coupling with amines to generate amide bonds — a linkage ubiquitous in drug molecules — while the boronate ester supports Suzuki coupling to introduce diverse aryl or heteroaryl fragments that modulate potency, selectivity, and physicochemical properties.

Biaryl carboxylic acids produced via Suzuki coupling of this compound can serve as direct pharmacophores in angiotensin receptor antagonists (sartans), kinase inhibitors, and PPAR modulators, among other therapeutic classes. The 2-methyl group adds conformational restriction that can improve binding selectivity by enforcing a preferred dihedral angle in the biaryl system.

Fragment-based drug discovery (FBDD) programs frequently use small, bifunctional fragments to grow or link hits into lead compounds. M693000, with its molecular weight appropriate for a fragment and two independently functionalizable groups, is well-suited to this strategy.